Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INS365 in Non-Sjogren's Dry Eye (CAE Study)
NCT00037661Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2002
- Primary completion
- Mar 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in dry eye disease (DED) comparing INS365 with Placebo (2 arms). Primary endpoints: Corneal Fluorescein Staining Score and Dry Eye Symptom Score. Started Apr 2002; status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00037661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00037661.